Zymeworks is a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases. Zymeworks’ complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Janus Parent, Inc.
SEC CIK
Corporate docs
Subsidiaries
Zymeworks CallCo ULC • Zymeworks ExchangeCo Ltd. • Zymeworks BC Inc. • Zymeworks Management Inc. • Zymeworks Biopharmaceuticals Inc. • Zymeworks Pharmaceuticals Limited • Zymeworks Lifesciences Pte. Ltd. ...
Latest filings (excl ownership)
10-Q
2024 Q3
Quarterly report
31 Oct 24
8-K
Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial Results
31 Oct 24
ARS
2023 FY
Annual report to shareholders
29 Oct 24
DEFA14A
Additional proxy soliciting materials
29 Oct 24
DEF 14A
Definitive proxy
29 Oct 24
8-K
Departure of Directors or Certain Officers
18 Oct 24
8-K
Departure of Directors or Certain Officers
3 Sep 24
8-K
Entry into a Material Definitive Agreement
2 Aug 24
424B5
Prospectus supplement for primary offering
2 Aug 24
8-K
Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock
1 Aug 24
Transcripts
Earnings call transcript
2024 Q2
1 Aug 24
Earnings call transcript
2024 Q1
2 May 24
Earnings call transcript
2023 Q4
6 Mar 24
Earnings call transcript
2023 Q3
7 Nov 23
Earnings call transcript
2023 Q2
10 Aug 23
Earnings call transcript
2023 Q1
8 May 23
Earnings call transcript
2022 Q4
7 Mar 23
Earnings call transcript
2022 Q3
9 Nov 22
Latest ownership filings
4
LEONE D PATTERSON
3 Sep 24
3
LEONE D PATTERSON
3 Sep 24
144
Notice of proposed sale of securities
11 Jun 24
4
Neil Gallagher
2 Apr 24
3
Neil Gallagher
2 Apr 24
3
Scott Platshon
4 Mar 24
SC 13D
EcoR1 Capital, LLC
22 Feb 24
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
SC 13G/A
PERCEPTIVE ADVISORS LLC
14 Feb 24
SC 13G/A
Redmile Group, LLC
14 Feb 24
Financial summary
| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 122.36 mm | 122.36 mm | 122.36 mm | 122.36 mm | 122.36 mm | 122.36 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 11.40 mm | 11.53 mm | 1.96 mm | 4.55 mm |
| Cash used (since last report) | n/a | n/a | 11.81 mm | 11.94 mm | 2.03 mm | 4.71 mm |
| Cash remaining | n/a | n/a | 110.55 mm | 110.42 mm | 120.33 mm | 117.64 mm |
| Runway (months of cash) | n/a | n/a | 9.7 | 9.6 | 61.4 | 25.9 |
Institutional ownership, Q2 2024
99.6% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 162 |
| Opened positions | 28 |
| Closed positions | 31 |
| Increased positions | 59 |
| Reduced positions | 49 |
| 13F shares | Current |
|---|---|
| Total value | 554.61 bn |
| Total shares | 70.73 mm |
| Total puts | 99.00 k |
| Total calls | 54.70 k |
| Total put/call ratio | 1.8 |
| Largest owners | Shares | Value |
|---|---|---|
| EcoR1 Capital | 13.44 mm | $114.35 bn |
| BVF | 5.87 mm | $49.95 bn |
| Redmile | 5.21 mm | $44.35 bn |
| MS Morgan Stanley | 4.24 mm | $36.08 bn |
| BLK BlackRock | 4.19 mm | $35.69 bn |
| Rubric Capital Management | 3.92 mm | $33.34 bn |
| All Blue Falcons FZE | 2.79 mm | $24.39 mm |
| Vanguard | 2.70 mm | $22.95 bn |
| Deutsche Bank AG - Registered Shares | 2.36 mm | $20.07 bn |
| BNP Paribas Asset Management Holding | 1.93 mm | $16.43 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Sep 24 | Patterson Leone D | Stock Option Common Stock | Grant | Acquire A | No | No | 11.73 | 360,000 | 4.22 mm | 360,000 |
| 2 Apr 24 | Neil Gallagher | Stock Option Common Stock | Grant | Acquire A | No | No | 9.23 | 74,000 | 683.02 k | 74,000 |